Appendix 3Y — Change of Director's Interest Notice

Imagion Biosystems gave ASX information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Read…


Appendix 2A — Fully Paid Ordinary Shares

Imagion Biosystems has submitted "Appendix 2A — Application for quotation of +securities." Read Appendix 2A.


Vesting of Performance Rights

Imagion Biosystems has advised that 2,500,000 performance rights have vested and were issued as ordinary shares to Executive Chairman and CEO Bob Proulx today,…